Pharmaceutical
ChemLinkedChemicalFoodCosmeticPharmaceuticalJapanAgrochemicalSustainability
News
Comprehensive coverage on the latest pharmaceutical regulatory update and industry activities in China.
INDUSTRY
Marketing Approval Priority Review Drug Registration New Drug
Monthly Report: New Drug Approvals in China | April 2021 In Apr. 2021, China NMPA approved a total of 12 new drugs. Eight of them are therapeutic biological products and the other four are chemical drugs.
May 14, 2021
INDUSTRY
Vaccine COVID-19
Introduction to China's COVID-19 Vaccines More than 235.97 million doses of COVID-19 vaccines have been administered across China by Apr. 27, 2021. The country has started its mass vaccination program and plans to vaccinate 40% of its population by June this year.
Apr 29, 2021
INDUSTRY
Marketing Approval Biological Product
Rapid Growth of Botulinum Toxin in China's Aesthetic Medicine Market With the major function to reduce the appearance of skin wrinkle, botulinum toxin injection has become one of the most favorable aesthetic medicine products by Chinese customers.
Apr 07, 2021
INDUSTRY
Law & Regulation Post-market
Adverse Drug Reaction in China: Important Numbers from 2020 Report In 2020, China's National Monitoring System of Adverse Drug Reaction (ADR) received a total number of 1.676 million reports of ADR events.
Mar 31, 2021
INDUSTRY
Law & Regulation Marketing Approval Innovative Drug
Ophthalmic Drug Market in China Attracts Increasing Attention In recent years, incidence rates of diseases like myopia, cataract, and dry eye syndrome have been growing year by year for all age groups in China.
Mar 22, 2021
INDUSTRY
Priority Review Health Insurance
In Light of the 14th Rare Disease Day, How Is China Doing on Rare Disease Drugs? On February 28, 2021, the international community observes the 14th Rare Disease Day, which is a time of the year to raise awareness among the general public and to also reflect upon the progress of orphan drugs development.
Mar 08, 2021
Pre 1... 56789
Most Popular